Cite
HARVARD Citation
Vanassche, T. et al. (2016). Reversal of dabigatran by idarucizumab: when and how?. Expert review of hematology. 9 (6), pp. 519-528. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vanassche, T. et al. (2016). Reversal of dabigatran by idarucizumab: when and how?. Expert review of hematology. 9 (6), pp. 519-528. [Online].